The effect of ipragliflozin on ectopic fat accumulation in non-obese type 2 diabetic patients with increased visceral fat - SGLT2 inhibitor and ectopic fat accumulation in diabetes

Tokyo Medical and Dental University0 个研究点目标入组 20 人开始时间: 2015年10月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients who are taking SGLT2 inhibitors Patients with insulin treatment Patients with severe diabetic retinopathy Patients who are hypersensitive to SGLT2 inhibitors Patients with cogestive heart failure (NYHA classification class III or IV) Patients with active infection, malignancy, severe liver or renal diseases Patients who had recently received operation or had severe trauma Patients who had experienced atherothrombotic events including myocardila infarction and/or stroke Patients with severe ketosis or diabetic coma/pre-coma Patients who are unable to figure out the consent due to dementia or impairment of consciousness Pregnant women, lactating woman, women who are planning to get pregnant Patients who were judged inadequate to enroll in the study by medical doctors

发起方